Align Technology, Inc. $ALGN Stock: Ieq Capital LLC Increases Position

Align Technology logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • IEQ Capital increased its Align Technology stake by 280.1% in the third quarter, adding 146,042 shares to hold 198,176 shares valued at about $26.4 million. Institutional investors collectively own 88.43% of the company.
  • Align reported quarterly EPS of $2.80, slightly above the $2.77 analyst consensus, and revenue of $1.01 billion, also ahead of estimates; revenue rose 1.9% year over year.
  • Analyst views were mixed, with a consensus rating of “Moderate Buy” and an average price target of $193.08. Several firms recently cut their price targets, while the stock’s cited Friday opening price was $159.68.
  • MarketBeat previews top five stocks to own in December.

Ieq Capital LLC grew its stake in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 280.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 198,176 shares of the medical equipment provider's stock after purchasing an additional 146,042 shares during the period. Ieq Capital LLC owned approximately 0.28% of Align Technology worth $26,443,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of ALGN. Bessemer Group Inc. grew its position in Align Technology by 37.2% in the 1st quarter. Bessemer Group Inc. now owns 247 shares of the medical equipment provider's stock valued at $43,000 after buying an additional 67 shares during the last quarter. Empirical Finance LLC boosted its stake in shares of Align Technology by 2.9% in the second quarter. Empirical Finance LLC now owns 2,570 shares of the medical equipment provider's stock valued at $433,000 after buying an additional 73 shares in the last quarter. First Bank & Trust boosted its stake in shares of Align Technology by 5.0% in the second quarter. First Bank & Trust now owns 1,599 shares of the medical equipment provider's stock valued at $270,000 after buying an additional 76 shares in the last quarter. M.E. Allison & CO. Inc. raised its position in Align Technology by 1.9% in the second quarter. M.E. Allison & CO. Inc. now owns 4,235 shares of the medical equipment provider's stock worth $714,000 after acquiring an additional 80 shares in the last quarter. Finally, Isthmus Partners LLC grew its stake in shares of Align Technology by 3.7% during the 3rd quarter. Isthmus Partners LLC now owns 2,601 shares of the medical equipment provider's stock worth $378,000 after purchasing an additional 92 shares during the period. Hedge funds and other institutional investors own 88.43% of the company's stock.

Align Technology Trading Down 2.6%

Shares of Align Technology stock opened at $159.68 on Friday. The company has a fifty day moving average price of $152.42 and a 200 day moving average price of $168.55. Align Technology, Inc. has a twelve month low of $132.63 and a twelve month high of $200.43. The stock has a market cap of $11.26 billion, a price-to-earnings ratio of 23.24, a price-to-earnings-growth ratio of 2.13 and a beta of 1.74.

Align Technology (NASDAQ:ALGN - Get Free Report) last posted its earnings results on Wednesday, October 28th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.77 by $0.03. The business had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1 billion. Align Technology had a return on equity of 15.96% and a net margin of 11.83%. The company's revenue for the quarter was up 1.9% compared to the same quarter last year. During the same quarter last year, the firm earned $2.61 earnings per share. Analysts forecast that Align Technology, Inc. will post 9.21 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms recently commented on ALGN. Stifel Nicolaus decreased their price objective on shares of Align Technology from $210.00 to $175.00 and set a "buy" rating on the stock in a report on Friday, October 9th. Mizuho lowered their price target on shares of Align Technology from $220.00 to $200.00 and set an "outperform" rating on the stock in a research report on Thursday, October 22nd. Raymond James Financial restated a "buy" rating on shares of Align Technology in a research report on Monday, October 5th. Wall Street Zen downgraded Align Technology from a "buy" rating to a "hold" rating in a research report on Saturday, October 24th. Finally, Morgan Stanley dropped their price objective on Align Technology from $188.00 to $175.00 and set an "equal weight" rating for the company in a research report on Thursday, October 29th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $193.08.

Read Our Latest Stock Report on Align Technology

About Align Technology

(Free Report)

Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.

Featured Stories

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN - Free Report).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Align Technology Right Now?

Before you consider Align Technology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.

While Align Technology currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines